Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Probiotics were shown to act positively on gut–brain axis signaling. We aimed to assess the effect of the administration of a new class of probiotics—psychobiotics—using data from individual psychometric scales, markers of the immune system and neuroactive metabolites. Medical databases were searched from database inception until 22 April 2021 for randomized clinical trials in clinically proven Major Depressive Disorder (MDD) patients treated with either probiotics or placebo reporting any psychometric score (PROSPERO registration number: CRD42021253024). Ten studies with 705 randomized participants and 603 analyzed were included. The mean age of individuals was 38.43 ± 12.1 years, predominantly women (n = 461, 76.45). The mean study duration was 48.8 ± 12.3 (range = 28–62) days. The dosage ranged between 1 × 109 to 2 × 1010 colony forming units (CFU)/day. We found that probiotics might alleviate symptoms of MDD; endpoint data (pooled scores): SMD = −0.292, 95%CI = −0.577 to −0.007, p < 0.044; change scores (BDI): SMD = −0.482, 95%CI = −0.854 to –0.109, p < 0.011; DM = −4.848, 95%CI = −8.559 to −1.137, p < 0.01. The therapy tended to be more effective with time of psychobiotic supplementation (coefficient = −0.12, SE = 0.06, Z = −1.84, p = 0.06) and in men (% of females: coefficient = 0.1, SE = 0.06, Z = 1.78, p = 0.07). Psychobiotics have great potential in the treatment of MDD. However, no specific strain/strains, dosage or duration of treatment can currently be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 Regression for SDM on strains used in trials. References [26,30], Formula 1 [23,28], Formula 2 [21].](https://figures.cochat.ai/paper-figures/ac0d68e27edc47bda900f05058becac2/effect-of-psychobiotics-on-psychometric-tests-and-inflammatory-markers-in-major-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [1]
In the citing paper
“Psychobiotics are modulators of the Microbiota-Gut-Brain Axis (MGBA) with promising benefits to mental health.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955
Cross-national epidemiology of DSM-IV major depressive episode
Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-90 · Cited by 2,221
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023
Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530 · cited 1×
“Some kynurenine catabolites may have a role in patients with MDD due to its neurotoxic and neurodegenerative effects [40].”
BackgroundThe central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513
Psychobiotics: A novel class of psychotropic
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287 · cited 1×
“Consequently, “psychobiotics,” which stands for probiotics that support mental health [12], are currently of great interest and hope for researchers, doctors and patients.”
BackgroundMajor depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792 · cited 1×
“, subclinical inflammation [3], hypothalamic–pituitary (HPA) axis dysregulation [4] and altered signaling of neurotrophic growth factors [5].”
BackgroundAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 6×
“One trial was sponsored by industry (N = 1) [29], and no data on sponsorship was available for three studies (N = 3) [21,22,25].”
BackgroundMethodInfluentialImpact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
A Nonparametric "Trim and Fill" Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. L. (2000) · Journal of the American Statistical Association · doi:10.2307/2669529 · Cited by 694
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561 · cited 1×
“There is, however, no current contention on whether probiotic treatments could/should successfully alter microbiota composition [31,32].”
BackgroundKazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534 · cited 12×
“References [26,30], Formula 1 [23,28], Formula 2 [21].”
BackgroundMethodInfluentialHuang, R., Wang, K., & Hu, J. (2016) · Nutrients · doi:10.3390/nu8080483 · Cited by 505
Rudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499 · cited 11×
“References [26,30], Formula 1 [23,28], Formula 2 [21].”
BackgroundInfluentialGender differences in chronic major and double depression
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Ryan, C. E., Hess, A. L., Harrison, W., et al. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00158-5 · Cited by 485
Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.98 · Cited by 437 · cited 1×
“, subclinical inflammation [3], hypothalamic–pituitary (HPA) axis dysregulation [4] and altered signaling of neurotrophic growth factors [5].”
BackgroundRecognizing Depression from the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061592 · Cited by 380
Gut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.102 · Cited by 372
A meta-analysis of the use of probiotics to alleviate depressive symptoms
Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.063 · Cited by 357
Vogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323 · cited 1×
“, subclinical inflammation [3], hypothalamic–pituitary (HPA) axis dysregulation [4] and altered signaling of neurotrophic growth factors [5].”
BackgroundRomijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323
Sex differences in gut microbiota in patients with major depressive disorder
Chen, J.-J., Zheng, P., Liu, Y.-Y., Zhong, X.-G., Wang, H.-Y., Guo, Y.-J., & Xie, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159322 · Cited by 272
Chahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.097 · Cited by 256
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249 · cited 1×
“Approximately 30% of patients with MDD do not respond to monoaminergic antidepressants [2], suggesting that other biological pathways are involved in MDD etiology.”
BackgroundKi Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.-D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.-S., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823712b1 · Cited by 216 · cited 1×
“There is, however, no current contention on whether probiotic treatments could/should successfully alter microbiota composition [31,32].”
BackgroundExploration of microbiota targets for major depressive disorder and mood related traits
Chung, Y.-C. E., Chen, H.-C., Chou, H.-C. L., Chen, I.-M., Lee, M.-S., Chuang, L.-C., Liu, Y.-W., Lu, M.-L., Chen, C.-H., Wu, C.-S., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.016 · Cited by 194
Szulińska, M., Łoniewski, I., Van Hemert, S., Sobieska, M., & Bogdański, P. (2018) · Nutrients · doi:10.3390/nu10060773 · Cited by 187
Self-citationFunctional Dynamics of the Gut Microbiome in Elderly People during Probiotic Consumption
Eloe-Fadrosh, E. A., Brady, A., Crabtree, J., Drabek, E. F., Ma, B., Mahurkar, A., Ravel, J., Haverkamp, M., Fiorino, A.-M., Botelho, C., et al. (2015) · mBio · doi:10.1128/mbio.00231-15 · Cited by 160 · cited 1×
“Nevertheless, probiotics were reported to influence bacterial gene expression and cause anti-inflammatory effects regardless of the influence on microbiota composition [33].”
BackgroundPROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression—A Randomized Controlled Trial
Reininghaus, E. Z., Platzer, M., Kohlhammer-Dohr, A., Hamm, C., Mörkl, S., Bengesser, S. A., Fellendorf, F. T., Lahousen-Luxenberger, T., Leitner-Afschar, B., Schöggl, H., et al. (2020) · Nutrients · doi:10.3390/nu12113422 · Cited by 157
Lai, W.-T., Deng, W.-F., Xu, S.-X., Zhao, J., Xu, D., Liu, Y.-H., Guo, Y.-Y., Wang, M.-B., He, F.-S., Ye, S.-W., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291719003027 · Cited by 146
Ghorbani, Z., Nazari, S., Etesam, F., Nourimajd, S., Ahmadpanah, M., & Razeghi Jahromi, S. (2018) · Archives of Neuroscience · doi:10.5812/archneurosci.60507 · Cited by 127
Effect of probiotics on depressive symptoms: a meta-analysis of human studies
Goh, K. K., Liu, Y.-W., Kuo, P.-H., Chung, Y.-C. E., Lu, M.-L., & Chen, C.-H. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112568 · Cited by 123
Amirani, E., Milajerdi, A., Mirzaei, H., Jamilian, H., Mansournia, M. A., Hallajzadeh, J., & Ghaderi, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102361 · Cited by 113
Nikolova, V., Cleare, A., Young, A., & Stone, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040647 · Cited by 106
From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders
Zagórska, A., Marcinkowska, M., Jamrozik, M., Wiśniowska, B., & Paśko, P. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0063 · Cited by 92
Heidarzadeh-Rad, N., Gökmen-Özel, H., Kazemi, A., Almasi, N., & Djafarian, K. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20079 · Cited by 86
Reiter, A., Bengesser, S. A., Hauschild, A.-C., Birkl-Töglhofer, A.-M., Fellendorf, F. T., Platzer, M., Färber, T., Seidl, M., Mendel, L.-M., Unterweger, R., et al. (2020) · Nutrients · doi:10.3390/nu12092575 · Cited by 78
Kazemi, A., Noorbala, A. A., Azam, K., & Djafarian, K. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.041 · Cited by 67
Nikolova, V., Zaidi, S. Y., Young, A. H., Cleare, A. J., & Stone, J. M. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319859963 · Cited by 66
Flux, M. C., & Lowry, C. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104578 · Cited by 65
Major Depressive Disorder and gut microbiota – Association not causation. A scoping review
Łoniewski, I., Misera, A., Skonieczna-Żydecka, K., Kaczmarczyk, M., Kaźmierczak-Siedlecka, K., Misiak, B., Marlicz, W., & Samochowiec, J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110111 · Cited by 61
Self-citationKim, J.-H., Cho, M. J., Hong, J. P., Bae, J. N., Cho, S.-J., Hahm, B.-J., Lee, D.-W., Park, J.-I., Lee, J.-Y., Jeon, H. J., et al. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.11.1659 · Cited by 51
Saccarello, A., Montarsolo, P., Massardo, I., Picciotto, R., Pedemonte, A., Castagnaro, R., Brasesco, P. C., Guida, V., Picco, P., Fioravanti, P., et al. (2020) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.19m02578 · Cited by 37
Hemert, S. V., & Ormel, G. (2014) · Food and Nutrition Sciences · doi:10.4236/fns.2014.518187 · Cited by 20
Research works printed but not linked: 1
- Ormel, 2014, Influence of the Multispecies Probiotic Ecologic® BARRIER on Parameters of Intestinal Barrier Function, Food Nutr. Sci., 5, 720
Cited by
Microbiota medicine: towards clinical revolution
Gebrayel, P., Nicco, C., Al Khodor, S., Bilinski, J., Caselli, E., Comelli, E. M., Egert, M., Giaroni, C., Karpinski, T. M., Loniewski, I., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03296-9 · Cited by 276
Self-citationPotential Role of Curcumin for the Treatment of Major Depressive Disorder
Lopresti, A. L. (2022) · CNS Drugs · doi:10.1007/s40263-022-00901-9 · Cited by 79
Ullah, H., Minno, A. D., Esposito, C., El-Seedi, H. R., Khalifa, S. A. M., Baldi, A., Greco, A., Santonastaso, S., Cioffi, V., Sperandeo, R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113930 · Cited by 60
Recent advances in therapeutic probiotics: insights from human trials
Cho, M.-Y., Eom, J.-H., Choi, E.-M., Yang, S., Lee, D., Kim, Y.-Y., Kim, H.-S., & Hwang, I. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00240-24 · Cited by 58
Slykerman, R. F., Davies, N., Vlčková, K., O’Riordan, K. J., Bassett, S. A., Dekker, J., Schellekens, H., Hyland, N. P., Clarke, G. A., & Patterson, E. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70079 · Cited by 50
Metadata
- Authors
- Misera, A., Liśkiewicz, P., Łoniewski, I., Skonieczna-Żydecka, K., & Samochowiec, J.
- Affiliations
- Pomeranian Medical University (PL)
- Department of Biochemical Sciences, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, Poland
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2021-09-23
- Volume
- 14
- Issue
- 10
- Pages
- 952
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC8541446
- OpenAlex
- W3200103522
- Cited by
- 34
- References
- 48
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 4 · 2023: 7 · 2022: 4
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- psychobiotics, major depressive disorder, probiotics, gut-brain axis, depressive symptoms, inflammatory markers, immune system, neuroactive metabolites, treatment duration, sex differences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.